Now the general public can join investors from around the world and own shares in Tombot: a robotics company transforming the daily lives of individuals, families, and communities facing health
adversities.

Animatronic artistry by Jim Henson's Creature Shop (creator of The Muppets)

Scientifically engineered to treat symptoms of mental illness

Aims to be the first robotic animal FDA device/health monitoring platform

A TIME Magazine "Best Invention" of 2020

1 billion people worldwide with serious mental health adversities

Initial clinical and marketing focus: older persons with dementia

$4.6M already raised from investors

Go To Market: Dementia

Millions of dementia patients are depressed, in pain, and dangerously medicated

Of the 55 million people worldwide with dementia, most suffer from loneliness, apathy, depression, hallucinations, or chronic pain. Doctors frequently prescribe psychotropic and opioid medications, but severe side effects reduce quality of life and increase risk of death.

For most, opioids and psychotropic drugs are the only treatment.

97% of Seniors with Dementia suffer from behavioral and psychological symptoms1

83% of nursing home residents have Chronic Pain2

Animal companionship has been shown to improve quality of life for nursing home residents and elders with dementia, but many seniors are unable to care for a live animal.

Meet Jennie

Voice Commands

Rechargeable

Interactive Sensors

Real Puppy Sounds

Software Updates

Tombot’s high-tech therapy robot Jennie is a masterful combination of art, science, and engineering. Engaging with Jennie provides joy, comfort, companionship, and a sense of security in the midst of destabilizing illness. Jennie is designed to alleviate the behavioral and psychological symptoms of dementia, including Sundowning Syndrome—a state of confusion common in dementia patients.

Rather than the looped programmed behavior you see in theme park animatronics, Jennie is uniquely interactive and autonomous, with patent-pending behaviors that closely mimic a real puppy.

Tombot anticipates our patent-pending IP will be protected by FDA regulation as a medical device, and ultimately attain public and private health insurance reimbursements.

Big Opportunity

High GP revenue model: Multi-Billion Dollar Market

Strong Team

Relevant domain expertise with track record of success

Institutional Investors

Lead: Wavemaker 360 Health

Opportunity

Sustainable Differentiators

IP granted and regulatory protection

Product Market Fit

Large customer studies and institutional research partners

Our mission is to transform the lives of the one billion people worldwide who face serious mental health adversities. As we finalize the production and fulfillment of the first Jennie orders, we’re raising capital to:


Jennie has caught the eye of several prominent institutional investors, and we’ve already raised significant funds from angels, VCs, corporate VC, and family offices.

*4.6M raised as of 9/8/22

Tombot Investors Blog

Fireside Chat: CC DeGraff and Leandra Sims of The Kensington

  Hello, I'm Tom Stevens. I recently had the opportunity to sit down wi...

Engineering Update October 2021

  Hello, I'm Tom Stevens, CEO and Co-Founder of Tombot. We’ve created J...

Fireside Chat With Jay Goss

Hello Tombot family, I'm Tom Stevens. We recently held a Fireside Chat ...

The Top 5 Reasons to Invest in Tombot

  Hello, I'm Tom Stevens, CEO and Co-Founder of Tombot, and we’ve creat...

Tombot Fireside Chat: Lead Investor, Bob Peisner, Explains Why He Invested

Hello. I'm Tom Stevens. Welcome to the Tombot Fireside Chat series. Fir...

A Brief Rundown of Jennie's Features and How to Clean Her!

Hello Tombot family. I'm Tom Stevens, CEO and Co-Founder of Tombot. We ...

Investors Explain Why They Believe in Tombot

  At Tombot we've created a robotic dog named Jennie, who is a fully int...

CEO, Tom Stevens, Pitches to Potential Investors

 Hello, Tombot family. I'm Tom Stevens, CEO and Co-Founder of Tombot.  ...

Tombot KPI Report and Engineering Updates

  At Tombot, we are developing the world’s most realistic, affordable, ...